{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T01:58:10Z","timestamp":1788919090326,"version":"build-2803163510"},"reference-count":66,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,6]],"date-time":"2016-07-06T00:00:00Z","timestamp":1467763200000},"content-version":"vor","delay-in-days":858,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.jtcvs.2013.10.008","type":"journal-article","created":{"date-parts":[[2013,12,12]],"date-time":"2013-12-12T10:30:17Z","timestamp":1386844217000},"page":"855-862","source":"Crossref","is-referenced-by-count":12,"title":["Management of antiplatelet therapy resistance in cardiac surgery"],"prefix":"10.1016","volume":"147","author":[{"given":"Hrvoje","family":"Gasparovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mate","family":"Petricevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bojan","family":"Biocina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtcvs.2013.10.008_bib1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejcts.2008.03.023","article-title":"Aspirin in coronary artery bypass surgery: new aspects of and alternatives for an old antithrombotic agent","volume":"34","author":"Zimmermann","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/bmj.308.6922.159","article-title":"Collaborative overview of randomised trials of antiplatelet therapy\u2013II: maintenance of vascular graft or arterial patency by antiplatelet therapy. Antiplatelet Trialists' Collaboration","volume":"308","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib3","first-page":"V71","article-title":"Long-term fate of bypass grafts: the Coronary Artery Surgery Study (CASS) and Montreal Heart Institute experiences","volume":"72","author":"Bourassa","year":"1985","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM198401263100401","article-title":"Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations","volume":"310","author":"Chesebro","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib5","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1136\/heartjnl-2012-302449","article-title":"Aspirin plus clopidogrel for optimal platelet inhibition following off-pump coronary artery bypass surgery: results from the CRYSSA (prevention of Coronary arteRY bypaSS occlusion After off-pump procedures) randomised study","volume":"98","author":"Mannacio","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib6","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1001\/jama.294.19.2446","article-title":"Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial","volume":"294","author":"Alexander","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib7","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1161\/01.CIR.97.9.916","article-title":"Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention","volume":"97","author":"Motwani","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib8","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/0735-1097(95)00280-4","article-title":"Recurrence of angina after coronary artery bypass surgery: predictors and prognosis (CASS Registry). Coronary Artery Surgery Study","volume":"26","author":"Cameron","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib9","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1056\/NEJMoa0804626","article-title":"Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease","volume":"360","author":"Serruys","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejcts.2008.02.024","article-title":"Guideline on antiplatelet and anticoagulation management in cardiac surgery","volume":"34","author":"Dunning","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib11","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0140-6736(84)92446-2","article-title":"Improved aortocoronary bypass patency by low-dose aspirin (100 mg daily). Effects on platelet aggregation and thromboxane formation","volume":"1","author":"Lorenz","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib12","first-page":"II218","article-title":"The effect of antiplatelet therapy on saphenous vein coronary artery bypass graft patency","volume":"68","author":"Sharma","year":"1983","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib13","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.jacc.2010.08.650","article-title":"Effects of aspirin responsiveness and platelet reactivity on early vein graft thrombosis after coronary artery bypass graft surgery","volume":"57","author":"Gluckman","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib14","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1067\/mtc.2001.111416","article-title":"Aspirin resistance after coronary artery bypass grafting","volume":"121","author":"Zimmermann","year":"2001","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib15","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/ncpcardio0602","article-title":"Drug insight: clopidogrel nonresponsiveness","volume":"3","author":"Gurbel","year":"2006","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib16","doi-asserted-by":"crossref","first-page":"541","DOI":"10.4070\/kcj.2013.43.8.541","article-title":"Genotype- and phenotype-directed personalization of antiplatelet treatment in patients with non-ST elevation acute coronary syndromes undergoing coronary stenting","volume":"43","author":"Ahn","year":"2013","journal-title":"Korean Circ J"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1124\/dmd.31.1.53","article-title":"The metabolism of clopidogrel is catalyzed by human cytochrome P450 3A and is inhibited by atorvastatin","volume":"31","author":"Clarke","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib18","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/01.CIR.0000047060.60595.CC","article-title":"Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: a new drug-drug interaction","volume":"107","author":"Lau","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0021-9150(01)00606-2","article-title":"Statins do not affect platelet inhibition with clopidogrel during coronary stenting","volume":"159","author":"Serebruany","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib20","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1161\/01.CIR.0000088780.57432.43","article-title":"Lack of adverse clopidogrel-atorvastatin clinical interaction from secondary analysis of a randomized, placebo-controlled clopidogrel trial","volume":"108","author":"Saw","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib21","doi-asserted-by":"crossref","first-page":"e004564","DOI":"10.1161\/JAHA.112.004564","article-title":"Impact of proton pump inhibitor therapy on the efficacy of clopidogrel in the CAPRIE and CREDO trials","volume":"2","author":"Dunn","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib22","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0140-6736(09)61525-7","article-title":"Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials","volume":"374","author":"O'Donoghue","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib23","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1093\/eurheartj\/ehm226","article-title":"A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease","volume":"28","author":"Lordkipanidze","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00380-011-0216-3","article-title":"Assessment of platelet function by whole blood impedance aggregometry in coronary artery bypass grafting patients on acetylsalicylic acid treatment may prompt a switch to dual antiplatelet therapy","volume":"28","author":"Petricevic","year":"2013","journal-title":"Heart Vessels"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib25","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1161\/01.CIR.0000013777.21160.07","article-title":"Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events","volume":"105","author":"Eikelboom","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib26","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1161\/01.CIR.0000130846.46168.03","article-title":"Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction","volume":"109","author":"Matetzky","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib27","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/CIRCULATIONAHA.108.812636","article-title":"Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up","volume":"119","author":"Marcucci","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib28","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1160\/TH10-08-0554","article-title":"Clopidogrel withdrawal: is there a \u201crebound\u201d phenomenon?","volume":"105","author":"Sambu","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/CIRCINTERVENTIONS.111.967208","volume":"5","author":"Mahla","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib30","article-title":"Thienopyridines resistance and recovery of platelet function after discontinuation of thienopyridines in cardiac surgery patients","author":"Di Dedda","year":"2013","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib31","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/1745-6215-13-148","article-title":"Dual antiplatelet therapy in patients with aspirin resistance following coronary artery bypass grafting: study protocol for a randomized controlled trial [NCT01159639]","volume":"13","author":"Gasparovic","year":"2012","journal-title":"Trials"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib32","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1745-6215-13-48","volume":"13","author":"Rafiq","year":"2012","journal-title":"Trials"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib33","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S0002-9149(03)00163-2","article-title":"Durability of platelet inhibition by clopidogrel","volume":"91","author":"Gurbel","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib34","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1161\/01.CIR.0000072771.11429.83","article-title":"Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity","volume":"107","author":"Gurbel","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib35","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/01.ftd.0000158084.84071.41","article-title":"Resistance to aspirin in patients after coronary artery bypass grafting is transient: impact on the monitoring of aspirin antiplatelet therapy","volume":"27","author":"Golanski","year":"2005","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib36","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.jtcvs.2007.11.033","article-title":"Detection and duration of aspirin resistance after coronary artery bypass grafting","volume":"135","author":"Zimmermann","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib37","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.thromres.2005.02.005","article-title":"Effect of increasing doses of aspirin on platelet function as measured by PFA-100 in patients with diabetes","volume":"116","author":"Abaci","year":"2005","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib38","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1160\/TH07-10-0624","article-title":"How to optimise clopidogrel therapy? Reducing the low-response incidence by aggregometry-guided therapy modification","volume":"99","author":"Neubauer","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib39","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.carrev.2012.02.009","article-title":"Doubling the clopidogrel dose in patients with reduced responsiveness to the standard dose is associated with a limited effectiveness as evaluated by impedance aggregometry","volume":"13","author":"Stellbaum","year":"2012","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1741-7015-9-3","article-title":"Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance\u2013the BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy","volume":"9","author":"Neubauer","year":"2011","journal-title":"BMC Med"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib41","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00380-010-0054-8","article-title":"Effects of various doses of aspirin on platelet activity and endothelial function","volume":"26","author":"Furuno","year":"2011","journal-title":"Heart Vessels"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib42","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1540-8191.2007.00475.x","article-title":"Clopidogrel is safe early after on- and off-pump coronary artery bypass surgery","volume":"22","author":"Chan","year":"2007","journal-title":"J Card Surg"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib43","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11239-012-0798-3","article-title":"Bleeding risk assessment using multiple electrode aggregometry in patients following coronary artery bypass surgery","volume":"35","author":"Petricevic","year":"2013","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib44","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nrcardio.2011.96","article-title":"The evolution of antiplatelet therapy in cardiovascular disease","volume":"8","author":"Yousuf","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib45","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib46","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jacc.2012.03.030","article-title":"Mortality benefit with prasugrel in the TRITON-TIMI 38 coronary artery bypass grafting cohort: risk-adjusted retrospective data analysis","volume":"60","author":"Smith","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib47","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(13)60141-5","article-title":"Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial","volume":"381","author":"Mohr","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib48","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib49","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1161\/CIRCULATIONAHA.109.919456","article-title":"Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study","volume":"121","author":"Gurbel","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib50","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1056\/NEJMoa1300815","article-title":"Effect of platelet inhibition with cangrelor during PCI on ischemic events","volume":"368","author":"Bhatt","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib51","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00228-012-1360-0","article-title":"Impaired bioavailability and antiplatelet effect of high-dose clopidogrel in patients after cardiopulmonary resuscitation (CPR)","volume":"69","author":"Souckova","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib52","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/jama.2011.2002","article-title":"Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial","volume":"307","author":"Angiolillo","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib53","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1056\/NEJMoa1200933","article-title":"Vorapaxar in the secondary prevention of atherothrombotic events","volume":"366","author":"Morrow","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib54","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/01.CIR.0000112378.09325.F9","article-title":"Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance","volume":"109","author":"Lau","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib55","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.athoracsur.2010.11.078","article-title":"2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines","volume":"91","author":"Ferraris","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib56","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.athoracsur.2010.09.022","article-title":"Multiple electrode whole-blood aggregometry and bleeding in cardiac surgery patients receiving thienopyridines","volume":"91","author":"Ranucci","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib57","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/heartjnl-2011-301164","article-title":"Personalised antiplatelet therapy in stent thrombosis: observations from the Clopidogrel Resistance in Stent Thrombosis (CREST) registry","volume":"98","author":"Sambu","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib58","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.ejcts.2009.12.044","article-title":"Modified thromboelastography evaluation of platelet dysfunction in patients undergoing coronary artery surgery","volume":"37","author":"Preisman","year":"2010","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib59","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1365-2362.2009.02175.x","article-title":"Postoperative development of aspirin resistance following coronary artery bypass","volume":"39","author":"Kempfert","year":"2009","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib60","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.jtcvs.2008.03.052","article-title":"Platelet activity and aspirin efficacy after off-pump compared with on-pump coronary artery bypass surgery: results from the prospective randomized trial PRAGUE 11-Coronary Artery Bypass and REactivity of Thrombocytes (CABARET)","volume":"136","author":"Bednar","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib61","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ejcts.2004.12.061","article-title":"Platelet function tests predict bleeding and thrombotic events after off-pump coronary bypass grafting","volume":"27","author":"Poston","year":"2005","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib62","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1160\/TH06-05-0242","article-title":"Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood","volume":"96","author":"Toth","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib63","series-title":"21st World Congress World Society of Cardio-Thoracic Surgeons","first-page":"70","article-title":"Definition of acetylsalicylic acid resistance using multiple electrode aggregometry in patients following coronary artery bypass grafting","volume":"Vol 14","author":"Petricevic","year":"2011"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib64","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ijcard.2008.11.031","article-title":"Initial patency of the infarct-related artery in patients with acute ST elevation myocardial infarction is related to platelet response to aspirin","volume":"140","author":"Skoric","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib65","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1213\/ane.0b013e3181a27d10","article-title":"Whole blood multiple electrode aggregometry is a reliable point-of-care test of aspirin-induced platelet dysfunction","volume":"109","author":"Jambor","year":"2009","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jtcvs.2013.10.008_bib66","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ahj.2010.05.034","article-title":"Adenosine diphosphate-induced platelet-fibrin clot strength: a new thrombelastographic indicator of long-term poststenting ischemic events","volume":"160","author":"Gurbel","year":"2010","journal-title":"Am Heart J"}],"container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522313012221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522313012221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,4]],"date-time":"2019-08-04T16:57:38Z","timestamp":1564937858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022522313012221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0022522313012221"],"URL":"https:\/\/doi.org\/10.1016\/j.jtcvs.2013.10.008","relation":{},"ISSN":["0022-5223"],"issn-type":[{"value":"0022-5223","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}